[S3 Guideline: Treating Chronic Respiratory Failure with Non-invasive Ventilation]

Area of Science:

• Pulmonology and Respiratory Medicine
• Medical Guidelines and Best Practices

Background:

• The previous S2k guideline (2017) combined invasive and non-invasive ventilation, necessitating an update due to increased evidence and patient numbers.
• Chronic respiratory failure affects diverse patient groups including those with COPD, thoraco-restrictive diseases, obesity-hypoventilation syndrome, and neuromuscular diseases.

Purpose of the Study:

• To provide comprehensive, evidence-based recommendations for non-invasive ventilation (NIV) in treating chronic respiratory failure.
• To enhance patient care by offering clear indications, therapy protocols, and follow-up strategies.
• To separate NIV recommendations from invasive ventilation, creating a focused and distinct guideline.

Main Methods:

• Development of an S3-level guideline based on the latest scientific evidence.
• Systematic review and synthesis of current research on NIV for chronic respiratory failure.
• Inclusion of detailed treatment pathways and patient care recommendations.

Main Results:

• Publication of a distinct S3 guideline for non-invasive ventilation, replacing the 2017 S2k guideline.
• Introduction of updated evidence-based recommendations for NIV application, settings, and follow-up.
• Inclusion of new sections on patient care, detailed treatment algorithms, and ethical considerations, including end-of-life care.

Conclusions:

• The S3 guideline serves as a crucial tool for healthcare professionals to optimize the management of chronic respiratory failure using NIV.
• The guideline's user-friendly format and comprehensive approach aim to improve treatment accessibility and efficacy.
• This guideline is valid until July 2027, emphasizing the need for ongoing updates in respiratory care.